Advisor Group Holdings, Inc. Purple Biotech Ltd. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$2.45 - $4.3 $12 - $21	5 New	5 $0
Q1 2021 May 13, 2021	SELL	$3.93 - $6.99 $1,768 - $3,145	-450 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.81 - $4.73 $1,714 - $2,128	450 New	450 $2,000

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.